Analyst Downgrades: Gilead Sciences, Inc., Adeptus Health Inc, and Tableau Software Inc

Analysts downwardly revised their ratings and price targets on Gilead Sciences, Inc. (NASDAQ:GILD), Adeptus Health Inc (NYSE:ADPT), and Tableau Software Inc (NYSE:DATA)

Nov 2, 2016 at 9:56 AM
facebook X logo linkedin


Analysts are weighing in on biotech stock Gilead Sciences, Inc. (NASDAQ:GILD), healthcare concern Adeptus Health Inc (NYSE:ADPT), and tech expert Tableau Software Inc (NYSE:DATA). Here's a quick roundup of today's bearish brokerage notes on GILD, ADPT, and DATA.

  • Analysts are trimming their expectations for GILD, after the company's disappointing quarterly results. For instance, Leerink was one of at least six brokerage firms to cut its price target, lowering its mark to $89 from $94. Of course, that's still well above GILD's current trading level of $72.97, down 1.5% today. Nevertheless, it's been an ugly year for Gilead Sciences, Inc. stock, falling 27%. Making matters worse, it would seem GILD is vulnerable to a round of downgrades, as 11 of 20 brokerage firms recommend buying the shares, and none give them a "sell" rating. 
  • ADPT is plummeting 61.6% to $10.33 -- just off a new record low of $10.10 -- after law firms Johnson & Weaver, LLP and Glancy Prongay & Murray LLP both announced investigations into whether the company violated federal securities laws. Meanwhile, Adeptus Health Inc woefully missed Wall Street's earnings estimates, and said "we have engaged Goldman Sachs to explore various financing alternatives." As such, Jefferies slashed its price target to $13 from $77 and downgraded the stock to "hold" from "buy," while BofA-Merrill Lynch downgraded it to "underperform." Keybanc also chimed its with a price-target cut to $31 from $59. This is all fantastic news for short sellers, though, who control over half of the stock's total float, and who have watched the stock lose roughly 86% of its value since its May high above $73. 
  • DATA is in the midst of a post-earnings slide of its own, as Wall Street punishes the stock for its quarterly revenue miss. No fewer than 18 brokerage firms have already reduced their price targets, with the lowest mark coming from Maxim, at $24. As such, Tableau Software Inc is off 11.9% at $43.61, though it had already been struggling amid overhead pressure from its 200-day moving average -- even as M&A rumors swirl. At the same time, short interest increased by almost 25% in the latest reporting period, so today's sell-off isn't bad news for everyone. 
Find out where the Dow lands right after the closing bell. Sign up now for Schaeffer's Market Recap
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI